The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

Market Cap	9.11B
Revenue (ttm)	11.80B
Net Income (ttm)	632.83M
Shares Out	31.24M
EPS (ttm)	20.25
PE Ratio	14.40
Forward PE	12.62
Dividend	6.30 (2.16%)
Ex-Dividend Date	Oct 28, 2024

Volume	4,140
Average Volume	7,309
Open	290.90
Previous Close	290.90
Day's Range	289.20 - 293.00
52-Week Range	223.50 - 384.80
Beta	0.21
RSI	57.70
Earnings Date	Aug 28, 2025

About DSE:IBNSINA

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflamma...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 4,200
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: IBNSINA

Financial Performance

In 2024, DSE:IBNSINA's revenue was 11.37 billion, an increase of 24.61% compared to the previous year's 9.13 billion. Earnings were 670.52 million, an increase of 10.75%.